Literature DB >> 25417712

Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.

Nancy F Crum-Cianflone1, Xun Wang, Anuradha Ganesan, Jason Okulicz, Amy Weintrob, Tahaniyat Lalani, Brian Agan.   

Abstract

Whether poor virologic control is associated with incident cancers after initiation of combination antiretroviral therapy (ART) remains unclear. In a large cohort, time-updated HIV RNA levels ≥1,000 copies/ml predicted AIDS-defining cancers (ADCs), non-AIDS-defining cancers (NADCs), and skin cancers. Virologic control may be an important strategy in reducing cancer events among HIV-infected persons.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25417712      PMCID： PMC4426326          DOI： 10.1089/AID.2014.0279

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  19 in total

1.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

2.  HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.

Authors:  Chad J Achenbach; Ashley L Buchanan; Stephen R Cole; Lifang Hou; Michael J Mugavero; Heidi M Crane; Richard D Moore; Richard H Haubrich; Satish Gopal; Joseph J Eron; Peter W Hunt; Benigno Rodriguez; Kenneth Mayer; Michael S Saag; Mari M Kitahata
Journal:  Clin Infect Dis       Date:  2014-02-12       Impact factor: 9.079

3.  Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.

Authors:  Mathias Bruyand; Rodolphe Thiébaut; Sylvie Lawson-Ayayi; Pierre Joly; Annie Jeanne Sasco; Patrick Mercié; Jean Luc Pellegrin; Didier Neau; François Dabis; Philippe Morlat; Geneviève Chêne; Fabrice Bonnet
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

4.  Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.

Authors:  Amy C Weintrob; Greg A Grandits; Brian K Agan; Anuradha Ganesan; Michael L Landrum; Nancy F Crum-Cianflone; Erica N Johnson; Claudia E Ordóñez; Glenn W Wortmann; Vincent C Marconi
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

5.  Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

Authors:  Elizabeth L Yanik; Sonia Napravnik; Stephen R Cole; Chad J Achenbach; Satish Gopal; Andrew Olshan; Dirk P Dittmer; Mari M Kitahata; Michael J Mugavero; Michael Saag; Richard D Moore; Kenneth Mayer; W Christopher Mathews; Peter W Hunt; Benigno Rodriguez; Joseph J Eron
Journal:  Clin Infect Dis       Date:  2013-06-04       Impact factor: 9.079

6.  Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Authors:  Thomas Powles; David Robinson; Justin Stebbing; Jonathan Shamash; Mark Nelson; Brian Gazzard; Sundhiya Mandelia; Henrik Møller; Mark Bower
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

7.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Authors: 
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

8.  Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

Authors:  Chun Chao; Wendy A Leyden; Lanfang Xu; Michael A Horberg; Daniel Klein; William J Towner; Charles P Quesenberry; Donald I Abrams; Michael J Silverberg
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

9.  Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans.

Authors:  Marc A Kowalkowski; Rena S Day; Xianglin L Du; Wenyaw Chan; Elizabeth Y Chiao
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

10.  Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.

Authors:  C J Li; C Wang; D J Friedman; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205
View more
  4 in total

1.  The US Military HIV Natural History Study: Informing Military HIV Care and Policy for Over 30 Years.

Authors:  Brian K Agan; Anuradha Ganesan; Morgan Byrne; Robert Deiss; Christina Schofield; Ryan C Maves; Jason Okulicz; Xiuping Chu; Thomas O'Bryan; Tahaniyat Lalani; Karl Kronmann; Tomas Ferguson; Merlin L Robb; Timothy J Whitman; Timothy H Burgess; Nelson Michael; Edmund Tramont
Journal:  Mil Med       Date:  2019-11-01       Impact factor: 1.437

2.  Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.

Authors:  Raúl U Hernández-Ramírez; Li Qin; Haiqun Lin; Wendy Leyden; Romain S Neugebauer; Keri N Althoff; Nancy A Hessol; Chad J Achenbach; John T Brooks; M John Gill; Surbhi Grover; Michael A Horberg; Jun Li; W Christopher Mathews; Angel M Mayor; Pragna Patel; Charles S Rabkin; Anita Rachlis; Amy C Justice; Richard D Moore; Eric A Engels; Michael J Silverberg; Robert Dubrow
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

3.  Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.

Authors:  Raúl U Hernández-Ramírez; Li Qin; Haiqun Lin; Wendy Leyden; Romain S Neugebauer; Keri N Althoff; Chad J Achenbach; Nancy A Hessol; Gypsyamber D'Souza; Kelly A Gebo; M John Gill; Surbhi Grover; Michael A Horberg; Jun Li; W Christopher Mathews; Angel M Mayor; Lesley S Park; Charles S Rabkin; Kate Salters; Amy C Justice; Richard D Moore; Eric A Engels; Michael J Silverberg; Robert Dubrow
Journal:  Lancet HIV       Date:  2019-02-27       Impact factor: 16.070

4.  Cancer incidence and risk factors in dialysis patients with human immunodeficiency virus: a cohort study.

Authors:  Mihir Patel; Jennifer L Waller; Stephanie L Baer; Vanessa Spearman; Mufaddal Kheda; Lufei Young; Stan Nahman; Rhonda E Colombo
Journal:  Clin Kidney J       Date:  2020-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.